FDA Investigator Joseph J Vannelli
Joseph J Vannelli has conducted inspections on 146 sites in 4 countries as of 27 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
146
Last Inspection Date:
27 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Belgium,
Switzerland,
Italy
FDA Investigators that have inspected at least one site in common with Joseph J Vannelli:
Alice S Tsao,
Althea A Williams,
Amanda T Zick,
Anastasia M Shields,
Ann B Okon,
Anna Lazar,
Arduino Frankovic,
Arthur G Hurst,
Azza Talaat,
Benton M Ketron,
Bijoy Panicker,
Bonita S Chester,
Brandy N Lepage,
Brenda A Kraengel,
Brian J Ryan,
Bruce G Cooper,
Cassandra L Winters,
Charanjeet Jassal,
Charisse K Green,
Charles M Edwards,
Charles R Cote, RIC,
Christopher S Fields,
Dana A Razzano,
Daniel L Aisen,
David A Carlson,
David M Mcnew,
David R Lattuca,
Deborah A Greco,
Dell S Moller,
Demitria J Argiropoulos,
Demitria J Xiradakis,
Denise L Terzian,
Diamond M Oden,
Dipesh K Shah,
Donald J Ullstrom,
Dr. Robert C Horan, MD,
Edmund F Mrak, Jr,
Edwin Melendez,
Elizabeth H Davis,
Elizabeth H Slazak,
Erika E Englund, PhD,
Erin L Nagel,
Felix Maldonado,
Frederick M Lochner,
George T Allen, Jr,
Harry J Brewer,
Helen B Ricalde,
Helen Verdel,
Hilary K Wagner,
Jackson Y See,
James A Liubicich,
James C Maclaughlin,
James D Bridges,
James R Wormuth,
Jazmine N Brown,
Jeanette L Mcginnis,
Jeanne F Broderick,
Jennifer J Edmiston,
Jessica L Pressley,
Joanne M Schlossin,
Joel R Merriman,
John A Podsadowski,
Johnna L Bleem,
Jose A Lopez,
Joseph A Famiglietti,
Joseph Milcetic,
Joseph R Lambert,
Joy P Matthias,
Joyce A Williams,
Judy Keihl,
Juliana M Badalucco,
Julie Scoma,
Karen A Morgante,
Karen L Kosar,
Kevin A Gonzalez,
Kim M Downing,
Kimberley A Gordon,
Kimberley A Ricketts,
Kimberly Y Smithson,
Kyle J Spencer,
Lauren E Blaser,
Leonard H Lavi,
Linda M Sacco,
Luella J Rossi,
Marc S Neubauer,
Marcellinus D Dordunoo,
Margaret E Sarles,
Margarita Santiago,
Marie Elena C Puleo,
Marlene L Davis,
Mary Alice B Garlipp,
Mary M Finn,
Mary P Murphy,
Marybeth Willis,
Matthew B Casale,
Matthew D Schnittker,
Melissa N Gregorio,
Michael A Charles,
Michael E Cimaglio,
Michael R Dominick,
Michael W Burd,
Miguel A Martinez Perez,
Mindy M Chou,
Morris Paul,
Mra B Kamberem,
Mra Mcculloughj,
Nancy M Espinal,
Nicholas A Violand,
Nicholas C Mendiola,
Niketa Patel,
Paige R Mccoy,
Parul M Patel,
Patricia A Clark,
Patrick C Klotzbuecher,
Paul E Stein,
Paul Mouris,
Penny H Mccarver,
Rajiv R Srivastava,
Regina M Bennett,
Richard K Glabach,
Ruben C Quintana,
Russ E Davis,
Russell J Glapion,
Samina S Khan,
Samuel T Walker,
Sandra A Hughes,
Sarah A Meehan,
Sasha M Latonis,
Satheesh Thomas,
Shannon A Dinardo,
Simone E Pitts,
Sony Mathews,
Susan D Yuscius,
Susan T Hadman,
Syeda N Mahazabin,
Tammy S Notto,
Tanya R Syffrard,
Thomas P Hansen,
Thomas W Nojek,
Vien Q Le,
Walden H Lee,
Wendy G Tan, PhD,
Wendy M Stone,
William J Leonard,
Yuyan Liang,
Yvesna C Blaise
Joseph J Vannelli's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2000 | FDA 483 | Fresenius Kabi USA, LLC - Form 483, 2000-02-25 |
April, 2004 | EIR | Once Again Nut Butter Collective, Inc. - EIR, 2004-03-15 |
January, 2002 | EIR | Contract Pharmaceuticals Limited Niagara - EIR, 2002-01-17 |
April, 2008 | FDA 483 | International Chemical Inc. - Form 483, 2008-04-11 |
July, 2006 | EIR | Contract Pharmaceuticals Limited Niagara - EIR, 2006-07-14 |
February, 2000 | FDA 483 Response | Fresenius Kabi USA, LLC - Form 483R, 2000-03-24 |
August, 2005 | FDA 483 Response | Contract Pharmaceuticals Limited Niagara - Form 483R, 2005-11-23 |
December, 2010 | EIR | Janssen Pharmaceutica NV - EIR, 2010-12-10 |
February, 2000 | EIR | Fresenius Kabi USA, LLC - EIR, 2000-02-25 |
August, 2003 | FDA 483 | ULTRAtab Laboratories, Inc. - Form 483, 2003-08-05 |
August, 2005 | FDA 483 | Contract Pharmaceuticals Limited Niagara - Form 483, 2005-08-08 |
August, 2005 | EIR | Contract Pharmaceuticals Limited Niagara - EIR, 2005-08-08 |
January, 2002 | EIR | Unither Manufacturing LLC - EIR, 2002-01-31 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more